2225 Stock Overview
An investment holding company, primarily engages in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Jinhai Medical Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.54 |
| 52 Week High | HK$2.36 |
| 52 Week Low | HK$0.20 |
| Beta | 0.052 |
| 1 Month Change | -32.01% |
| 3 Month Change | -0.32% |
| 1 Year Change | 167.83% |
| 3 Year Change | 146.40% |
| 5 Year Change | 250.00% |
| Change since IPO | 1,020.00% |
Recent News & Updates
Jinhai Medical Technology Limited's (HKG:2225) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Dec 16
Jinhai Medical Technology (HKG:2225) Has Debt But No Earnings; Should You Worry?
Nov 05Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price
Oct 06Recent updates
Jinhai Medical Technology Limited's (HKG:2225) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Dec 16Jinhai Medical Technology (HKG:2225) Has Debt But No Earnings; Should You Worry?
Nov 05Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price
Oct 06The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon
Jun 19Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%
May 13Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%
Mar 17What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You
Jan 31Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital
Jun 06Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital
Mar 07Shareholder Returns
| 2225 | HK Professional Services | HK Market | |
|---|---|---|---|
| 7D | -9.9% | -8.8% | -0.5% |
| 1Y | 167.8% | 14.5% | 19.9% |
Return vs Industry: 2225 exceeded the Hong Kong Professional Services industry which returned 14.5% over the past year.
Return vs Market: 2225 exceeded the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
| 2225 volatility | |
|---|---|
| 2225 Average Weekly Movement | 11.1% |
| Professional Services Industry Average Movement | 9.2% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 2225 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2225's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 508 | Zhenfei Wang | www.jin-hai.com.hk |
Jinhai Medical Technology Limited, an investment holding company, primarily engages in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. The company also provides dormitory services; information technology services; and construction ancillary services comprising warehousing and cleaning services, and building maintenance works. In addition, it engages in the engineering design and consultancy activities, and accommodation for foreign workers dormitory providers; is involved in the provision of minimally invasive surgery solutions, medical products, and related services, as well as sales of medical equipment; and graphene material products.
Jinhai Medical Technology Limited Fundamentals Summary
| 2225 fundamental statistics | |
|---|---|
| Market cap | HK$7.96b |
| Earnings (TTM) | -HK$58.09m |
| Revenue (TTM) | HK$341.97m |
23.3x
P/S Ratio-137.1x
P/E RatioIs 2225 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2225 income statement (TTM) | |
|---|---|
| Revenue | S$59.60m |
| Cost of Revenue | S$45.20m |
| Gross Profit | S$14.40m |
| Other Expenses | S$24.53m |
| Earnings | -S$10.12m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.002 |
| Gross Margin | 24.17% |
| Net Profit Margin | -16.99% |
| Debt/Equity Ratio | 19.8% |
How did 2225 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:37 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jinhai Medical Technology Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|